OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?
Bahareh Kashani, Zahra Zandi, Atieh Pourbagheri‐Sigaroodi, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 6, pp. 4121-4137
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Immunogenic Cell Death Induction by Ionizing Radiation
Mengqin Zhu, Mengdie Yang, Jiajia Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 181

The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
Ruixue Bai, Yunong Li, Lingyan Jian, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160

MMP9: A Tough Target for Targeted Therapy for Cancer
Katarzyna Augoff, Anita Hryniewicz‐Jankowska, Renata Taboła, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1847-1847
Open Access | Times Cited: 146

Anticancer Activity of Propolis and Its Compounds
Ewa Forma, Magdalena Bryś
Nutrients (2021) Vol. 13, Iss. 8, pp. 2594-2594
Open Access | Times Cited: 128

Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications
Yi-Hsin Chen, Kang‐Hsi Wu, Han‐Ping Wu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5037-5037
Open Access | Times Cited: 19

Paclitaxel and its semi-synthetic derivatives: comprehensive insights into chemical structure, mechanisms of action, and anticancer properties
Priyanka Sati, Eshita Sharma, Praveen Dhyani, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 18

The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
Xue Chen, Yunxiao Zhang, Yao Fu
Medicine in Drug Discovery (2022) Vol. 14, pp. 100122-100122
Open Access | Times Cited: 55

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
Congqi Shi, Kaiyu Qin, Anqi Lin, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 43

Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis
Yazdan Mokhtari, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 639-651
Open Access | Times Cited: 63

TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155
Jie Guo, Mengfan Liao, Jun Wang
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 45

Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease
Wenbin Dai, Longhai Long, Xiaoqiang Wang, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 34

Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer
John Gubatan, Theresa Louise Boye, Michelle Temby, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1371-1371
Open Access | Times Cited: 31

Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity
Natticha Sumneang, Pongpan Tanajak, Thura Tun Oo
Molecules (2023) Vol. 28, Iss. 11, pp. 4294-4294
Open Access | Times Cited: 20

The functions and regulatory pathways of S100A8/A9 and its receptors in cancers
Huimin Zhou, Cong Zhao, Rong‐Guang Shao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19

Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management
Vasiliki Katsi, Ilias Papakonstantinou, Konstantinos Tsioufis
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11786-11786
Open Access | Times Cited: 16

Interaction of Opioids with TLR4—Mechanisms and Ramifications
Mai Mahmoud Gabr, Iqira Saeed, Jared A. Miles, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5274-5274
Open Access | Times Cited: 30

Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands
Leila Rostamizadeh, Ommoleila Molavi, Mohsen Rashid, et al.
Bioimpacts (2022)
Open Access | Times Cited: 19

Forsythiasides: A review of the pharmacological effects
Hong-Xuan Yang, Qiuping Liu, Yanxi Zhou, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 19

The Tumor Microenvironment Mediates the HIF-1α/PD-L1 Pathway to Promote Immune Escape in Colorectal Cancer
Jing Sun, Zhengtian Zhao, Jiaqi Lu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3735-3735
Open Access | Times Cited: 4

Clinicopathological Significance and Prognostic Role of High Mobility Group Box 1 (HMGB1), Toll-Like Receptor (TLR) 2 and TLR4 in Breast Cancer
Reina Taguchi, M. Yamaguchi, Kiyoshi Takagi, et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2024) Vol. 57, Iss. 2, pp. 75-83
Open Access | Times Cited: 4

Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway
Y. Shi, Yu Tang, Zhiwei Sun, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 51-64
Open Access

Distinct immunological features of oropharyngeal cancer peritumoral tonsillar tissues from inflammatory tonsils and regional lymph nodes: A pilot study
Naohiro Wakisaka, Makiko Moriyama‐Kita, Satoru Kondo, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316102-e0316102
Open Access

Metastatic melanoma: An integrated analysis to identify critical regulators associated with prognosis, pathogenesis and targeted therapies
Zeinab Chaharlashkar, Yousof Saeedi Honar, Meghdad Abdollahpour‐Alitappeh, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0312754-e0312754
Open Access

Fusobacterium nucleatum exacerbates colitis via STAT3 activation induced by Acetyl-CoA accumulation
Zixuan Xiang, Xiangyun Li, Xiaoli Wang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top